By Timothy S. Donahue

Top Takeaways:

• Broughton increases its workforce by 15% across Yorkshire and Lancashire to meet rising demand.
• New hires enhance lab and regulatory abilities, aiding in method development, validation, and organized submissions.
• The company anticipates ongoing growth into 2026, with CEO Chris Allen mentioning strong client trust and sector expansion.

Analytical testing and regulatory consultancy Broughton has increased its workforce by 15% amid ongoing growth in demand for its laboratory and regulatory services. The company has created new roles at both its Coleby House location in Skipton, Yorkshire, and its Oak Tree House facility in Lancashire, as well as additional team leadership and business development positions.

The expansion enhances Broughton’s laboratory operations and commercial capacity, aligning with its plans to improve service capabilities into 2026. The company states that the recruitment also supports skilled scientific jobs in Lancashire and Yorkshire, two regions where demand for laboratory and regulatory expertise continues to increase and where local universities supply graduates pursuing technical scientific careers.

Broughton’s larger team supports the company’s growing order book in analytical testing and regulatory consulting, according to a press release. The company states that businesses in regulated markets are increasingly seeking clearer evidence collection and more organized regulatory planning to meet evolving expectations for product authorization and post-market oversight.

The new hires increase Broughton’s capacity for method development, validation, technical interpretation, and regulatory planning. The company states that the additional capability helps clients create coherent submissions and supports the development and maintenance of products throughout their commercial lifecycles.

“This is a period of planned expansion as we grow our laboratory and consultancy teams, expand into new markets and extend our service portfolio,” said Chris Allen, Chief Executive Officer of Broughton. “The level of testing activity we are seeing reflects the trust our clients place in us and the pace of development in the sectors we support.

“We are focused on sustainable growth that maintains scientific discipline while meeting rising demand. We expect this trajectory to continue into 2026 with further developments already underway.”

Broughton has also enhanced its commercial functions to better synchronize laboratory delivery with client project strategies, supporting continuity from early development through regulatory submissions and ongoing evidence generation after products reach the market.

The company states that the growth phase also enhances the region’s life sciences infrastructure. Broughton plans to continue investing in its facilities and service offerings to support clients operating in regulated environments where data quality and clear evidence are crucial for market access and commercial success.